These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27485720)

  • 21. Genetic Carrier Screening in the Twenty-first Century.
    Yao R; Goetzinger KR
    Clin Lab Med; 2016 Jun; 36(2):277-88. PubMed ID: 27235912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel.
    Broide E; Zeigler M; Eckstein J; Bach G
    Am J Med Genet; 1993 Aug; 47(2):213-5. PubMed ID: 8213907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expanding preconception carrier screening for the Jewish population using high throughput microfluidics technology and next generation sequencing.
    Gal M; Khermesh K; Barak M; Lin M; Lahat H; Reznik Wolf H; Lin M; Pras E; Levanon EY
    BMC Med Genomics; 2016 May; 9(1):24. PubMed ID: 27175728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a multi-disease carrier screening programme in Ashkenazi Jewish high schools.
    Ioannou L; Massie J; Lewis S; Petrou V; Gason A; Metcalfe S; Aitken MA; Bankier A; Delatycki MB
    Clin Genet; 2010 Jul; 78(1):21-31. PubMed ID: 20597919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ashkenazi Jewish population frequency of the Bloom syndrome gene 2281 delta 6ins7 mutation.
    Roa BB; Savino CV; Richards CS
    Genet Test; 1999; 3(2):219-21. PubMed ID: 10464671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experiences in molecular-based prenatal screening for Ashkenazi Jewish genetic diseases.
    Eng CM; Desnick RJ
    Adv Genet; 2001; 44():275-96. PubMed ID: 11596990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of preconceptional carrier screening for cystic fibrosis and haemoglobinopathies: a sociotechnical analysis.
    Achterbergh R; Lakeman P; Stemerding D; Moors EH; Cornel MC
    Health Policy; 2007 Oct; 83(2-3):277-86. PubMed ID: 17368860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A deleterious mutation in the PEX2 gene causes Zellweger syndrome in individuals of Ashkenazi Jewish descent.
    Fedick A; Jalas C; Treff NR
    Clin Genet; 2014 Apr; 85(4):343-6. PubMed ID: 23590336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for genetic disorders among Jews: how should the Tay-Sachs screening program be continued?
    Zlotogora J; Leventhal A
    Isr Med Assoc J; 2000 Sep; 2(9):665-7. PubMed ID: 11062764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hereditary breast cancer in Jews.
    Rubinstein WS
    Fam Cancer; 2004; 3(3-4):249-57. PubMed ID: 15516849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Ashkenazi Jewish carrier screening panel: evolution, status quo, and disparities.
    Hoffman JD; Park JJ; Schreiber-Agus N; Kornreich R; Tanner AK; Keiles S; Friedman KJ; Heim RA
    Prenat Diagn; 2014 Dec; 34(12):1161-7. PubMed ID: 24996053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population-based preconception carrier screening: how potential users from the general population view a test for 50 serious diseases.
    Plantinga M; Birnie E; Abbott KM; Sinke RJ; Lucassen AM; Schuurmans J; Kaplan S; Verkerk MA; Ranchor AV; van Langen IM
    Eur J Hum Genet; 2016 Oct; 24(10):1417-23. PubMed ID: 27165008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consanguineous couples' experiences and views regarding expanded carrier screening: Barriers and facilitators in the decision-making process.
    van der Hout S; Woudstra AJ; Dondorp W; Sallevelt S; de Die-Smulders C; Paulussen ADC; de Wert G
    Eur J Hum Genet; 2023 Nov; 31(11):1317-1322. PubMed ID: 37280360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experience of carrier couples identified through a population-based carrier screening pilot program for four founder autosomal recessive diseases in Saguenay-Lac-Saint-Jean.
    Tardif J; Pratte A; Laberge AM
    Prenat Diagn; 2018 Jan; 38(1):67-74. PubMed ID: 28419508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carrier screening of RTEL1 mutations in the Ashkenazi Jewish population.
    Fedick AM; Shi L; Jalas C; Treff NR; Ekstein J; Kornreich R; Edelmann L; Mehta L; Savage SA
    Clin Genet; 2015 Aug; 88(2):177-81. PubMed ID: 25047097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'A morass of considerations': exploring attitudes towards ethnicity-based haemoglobinopathy-carrier screening in primary care.
    Jans SM; Henneman L; de Jonge A; van El CG; van Tuyl LH; Cornel MC; Lagro-Janssen AL
    Fam Pract; 2013 Oct; 30(5):604-10. PubMed ID: 23629736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community attitudes towards a Jewish community BRCA1/2 testing program.
    Cousens N; Kaur R; Meiser B; Andrews L
    Fam Cancer; 2017 Jan; 16(1):17-28. PubMed ID: 27480161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors influencing uptake of genetic testing for colorectal cancer risk in an Australian Jewish population.
    Warner BJ; Curnow LJ; Polglase AL; Debinski HS
    J Genet Couns; 2005 Oct; 14(5):387-94. PubMed ID: 16195945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.